Cargando…
Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles
Antitumor applications of ascorbic acid (AA) and its oxidized form dehydroascorbic acid (DHA) can be quite challenging due to their instability and sensitivity to degradation in aqueous media. To overcome this obstacle, we have synthesized solid lipid nanoparticles loaded with ascorbyl palmitate (SL...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102913/ https://www.ncbi.nlm.nih.gov/pubmed/35566920 http://dx.doi.org/10.3390/polym14091751 |
_version_ | 1784707440072196096 |
---|---|
author | Ledinski, Maja Marić, Ivan Peharec Štefanić, Petra Ladan, Iva Caput Mihalić, Katarina Jurkin, Tanja Gotić, Marijan Urlić, Inga |
author_facet | Ledinski, Maja Marić, Ivan Peharec Štefanić, Petra Ladan, Iva Caput Mihalić, Katarina Jurkin, Tanja Gotić, Marijan Urlić, Inga |
author_sort | Ledinski, Maja |
collection | PubMed |
description | Antitumor applications of ascorbic acid (AA) and its oxidized form dehydroascorbic acid (DHA) can be quite challenging due to their instability and sensitivity to degradation in aqueous media. To overcome this obstacle, we have synthesized solid lipid nanoparticles loaded with ascorbyl palmitate (SLN-AP) with variations in proportions of the polymer Pluronic F-68. SLNs were synthesized using the hot homogenization method, characterized by measuring the particle size, polydispersity, zeta potential and visualized by TEM. To investigate the cellular uptake of the SLN, we have incorporated coumarin-6 into the same SLN formulation and followed their successful uptake for 48 h. We have tested the cytotoxicity of the SLN formulations and free ascorbate forms, AA and DHA, on HEK 293 and U2OS cell lines by MTT assay. The SLN-AP in both formulations have a cytotoxic effect at lower concentrations when compared to ascorbate applied the form of AA or DHA. Better selectivity for targeting tumor cell line was observed with 3% Pluronic F-68. The antioxidative effect of the SLN-AP was observed as early as 1 h after the treatment with a small dose of ascorbate applied (5 µM). SLN-AP formulation with 3% Pluronic F-68 needs to be further optimized as an ascorbate carrier due to its intrinsic cytotoxicity. |
format | Online Article Text |
id | pubmed-9102913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91029132022-05-14 Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles Ledinski, Maja Marić, Ivan Peharec Štefanić, Petra Ladan, Iva Caput Mihalić, Katarina Jurkin, Tanja Gotić, Marijan Urlić, Inga Polymers (Basel) Article Antitumor applications of ascorbic acid (AA) and its oxidized form dehydroascorbic acid (DHA) can be quite challenging due to their instability and sensitivity to degradation in aqueous media. To overcome this obstacle, we have synthesized solid lipid nanoparticles loaded with ascorbyl palmitate (SLN-AP) with variations in proportions of the polymer Pluronic F-68. SLNs were synthesized using the hot homogenization method, characterized by measuring the particle size, polydispersity, zeta potential and visualized by TEM. To investigate the cellular uptake of the SLN, we have incorporated coumarin-6 into the same SLN formulation and followed their successful uptake for 48 h. We have tested the cytotoxicity of the SLN formulations and free ascorbate forms, AA and DHA, on HEK 293 and U2OS cell lines by MTT assay. The SLN-AP in both formulations have a cytotoxic effect at lower concentrations when compared to ascorbate applied the form of AA or DHA. Better selectivity for targeting tumor cell line was observed with 3% Pluronic F-68. The antioxidative effect of the SLN-AP was observed as early as 1 h after the treatment with a small dose of ascorbate applied (5 µM). SLN-AP formulation with 3% Pluronic F-68 needs to be further optimized as an ascorbate carrier due to its intrinsic cytotoxicity. MDPI 2022-04-26 /pmc/articles/PMC9102913/ /pubmed/35566920 http://dx.doi.org/10.3390/polym14091751 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ledinski, Maja Marić, Ivan Peharec Štefanić, Petra Ladan, Iva Caput Mihalić, Katarina Jurkin, Tanja Gotić, Marijan Urlić, Inga Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles |
title | Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles |
title_full | Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles |
title_fullStr | Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles |
title_full_unstemmed | Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles |
title_short | Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles |
title_sort | synthesis and in vitro characterization of ascorbyl palmitate-loaded solid lipid nanoparticles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102913/ https://www.ncbi.nlm.nih.gov/pubmed/35566920 http://dx.doi.org/10.3390/polym14091751 |
work_keys_str_mv | AT ledinskimaja synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles AT maricivan synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles AT peharecstefanicpetra synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles AT ladaniva synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles AT caputmihalickatarina synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles AT jurkintanja synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles AT goticmarijan synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles AT urlicinga synthesisandinvitrocharacterizationofascorbylpalmitateloadedsolidlipidnanoparticles |